Get Your Personalized Supplement StackSupplement Stack Quiz

Potassium Glycinate Complex

Q: How long until BP effects appear?

Measurable changes in blood pressure typically appear within 2-4 weeks of consistent potassium bisglycinate supplementation. Individual responses may vary, and consistent monitoring is advised.

Q: Safe with hypertension medications?

Potassium bisglycinate supplementation requires medical supervision when taken with hypertension medications due to the risk of additive effects, potentially leading to hypotension or hyperkalemia. Consult a healthcare provider.

Q: Better than citrate/gluconate?

While potassium bisglycinate theoretically offers an absorption advantage due to glycine chelation, clinical equivalence to other forms like citrate or gluconate remains unproven. More research is needed to confirm any differential efficacy.

Also known as: Potassium bisglycinate, Potassium glycinate, Glycine-bound potassium

Overview

Potassium bisglycinate is a chelated form of potassium, where potassium is bound to the amino acid glycine. This synthetic chelate is designed to enhance potassium's bioavailability and absorption. It is primarily used to manage hypertension and maintain electrolyte balance. Potassium bisglycinate offers a neutral pH, potentially reducing gastrointestinal discomfort compared to other potassium salts. While research on potassium's benefits is extensive, studies specifically examining potassium glycinate are still emerging, with current data mainly focusing on pharmacokinetic properties. It is not naturally occurring and is manufactured as a supplement to address potassium deficiencies and support cardiovascular health.

Benefits

Potassium bisglycinate offers several potential benefits, primarily related to its potassium content. It has been shown to reduce blood pressure in normotensive adults, with studies indicating a decrease of approximately 3.49 mmHg in systolic blood pressure and 1.96 mmHg in diastolic blood pressure. It also plays a crucial role in maintaining electrolyte balance, ensuring serum potassium levels remain within the normal range of 3.5-5.0 mEq/L. The glycinate form may offer superior absorption compared to other forms like potassium gluconate, although more specific research is needed to confirm this advantage. These benefits are supported by meta-analyses and randomized controlled trials, although the evidence specific to the glycinate form is still limited.

How it works

Potassium bisglycinate works through several mechanisms. Potassium itself promotes vasodilation by enhancing endothelial nitric oxide production, which helps to relax blood vessels and lower blood pressure. It also counterbalances sodium levels by increasing renal sodium excretion, further aiding in blood pressure regulation. At the cellular level, potassium maintains membrane potential via the Na+/K+-ATPase pump, crucial for nerve and muscle function. The glycine chelation may enhance absorption by bypassing chloride-dependent transport mechanisms, potentially improving potassium uptake in the intestines.

Side effects

Common side effects of potassium bisglycinate, occurring in more than 5% of users, include gastrointestinal discomfort, which is often dose-dependent. Uncommon side effects (1-5%) may include a metallic taste and nausea. In rare cases (less than 1%), hyperkalemia can occur, particularly in individuals with renal impairment. Potassium bisglycinate can interact with certain medications, such as ACE inhibitors, potassium-sparing diuretics, and NSAIDs, potentially increasing the risk of hyperkalemia. It is contraindicated in individuals with chronic kidney disease (eGFR <60 mL/min) and adrenal insufficiency. Caution is advised, and medical supervision is recommended, especially for those with pre-existing conditions or taking interacting medications.

Dosage

The minimum effective dosage of potassium bisglycinate is around 20 mEq/day (780 mg elemental K+). The optimal range is typically between 40-60 mEq/day (1,560-2,340 mg), divided into multiple doses taken with meals to enhance absorption and minimize gastrointestinal discomfort. The maximum safe dosage for healthy adults is approximately 100 mEq/day (3,900 mg). Magnesium can act as a cofactor, synergistically enhancing the blood pressure-lowering effects of potassium. It's important to monitor potassium levels, especially when exceeding the recommended daily allowance, to avoid hyperkalemia.

FAQs

How long until BP effects appear?

Measurable changes in blood pressure typically appear within 2-4 weeks of consistent potassium bisglycinate supplementation. Individual responses may vary, and consistent monitoring is advised.

Safe with hypertension medications?

Potassium bisglycinate supplementation requires medical supervision when taken with hypertension medications due to the risk of additive effects, potentially leading to hypotension or hyperkalemia. Consult a healthcare provider.

Better than citrate/gluconate?

While potassium bisglycinate theoretically offers an absorption advantage due to glycine chelation, clinical equivalence to other forms like citrate or gluconate remains unproven. More research is needed to confirm any differential efficacy.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/27566636/ – This systematic review and meta-analysis of 15 RCTs (n=917) found that potassium supplementation increased serum potassium levels by 0.14 mEq/L (p<0.01) without significant changes in creatinine levels. The study highlights the overall effect of potassium supplementation on serum potassium but notes the heterogeneity of potassium forms used in the included trials.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4963920/ – This RCT bioavailability analysis involving 9 interventions (n=30) demonstrated a linear dose-response relationship for potassium supplementation within the range of 20-60 mEq. The study also indicated that potassium from food sources may be superior in terms of bioavailability compared to supplements, although the duration of the study was short (5-day phases).
https://www.mdpi.com/2072-6643/16/21/3617 – This meta-analysis of 12 RCTs (n=1,012) investigated the combined effects of magnesium and potassium supplementation, revealing a reduction in systolic blood pressure by 4.7 mmHg. The study suggests a synergistic effect between magnesium and potassium in managing blood pressure, although it acknowledges variability in dosing protocols across the included trials.
https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0174967 – This study investigates the effects of increased potassium intake on blood pressure and sodium excretion. It provides evidence supporting the role of potassium in regulating blood pressure through enhanced sodium excretion, contributing to the understanding of potassium's mechanism of action.
https://diabetesjournals.org/care/article/34/9/2116/38612/Magnesium-Intake-and-Risk-of-Type-2-DiabetesMeta – This meta-analysis explores the relationship between magnesium intake and the risk of type 2 diabetes. While not directly related to potassium glycinate, it highlights the importance of magnesium as a cofactor that can synergistically enhance the benefits of potassium, particularly in relation to blood pressure and metabolic health.